Cargando…

Moving beyond tight glucose control to safe effective glucose control

The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Krinsley, James S, Preiser, Jean-Charles
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481442/
https://www.ncbi.nlm.nih.gov/pubmed/18495050
http://dx.doi.org/10.1186/cc6889
_version_ 1782157992447180800
author Krinsley, James S
Preiser, Jean-Charles
author_facet Krinsley, James S
Preiser, Jean-Charles
author_sort Krinsley, James S
collection PubMed
description The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Safe, Effective Glucose Control – that will essentially target an intermediate blood glucose level. As compared with genuine tight glucose control, Safe, Effective Glucose Control – already used in many intensive care units worldwide – is intended to decrease the rate of hypoglycemia and the workload, while reducing the adverse effects of severe hyperglycemia.
format Text
id pubmed-2481442
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24814422008-07-24 Moving beyond tight glucose control to safe effective glucose control Krinsley, James S Preiser, Jean-Charles Crit Care Commentary The impressive benefits related to the use of tight glucose control by intensive insulin therapy have not been reproduced until now in multicenter large-scale prospective randomized trials. Although the reasons for these failures are not entirely clear, we suggest the use of a stepwise approach – Safe, Effective Glucose Control – that will essentially target an intermediate blood glucose level. As compared with genuine tight glucose control, Safe, Effective Glucose Control – already used in many intensive care units worldwide – is intended to decrease the rate of hypoglycemia and the workload, while reducing the adverse effects of severe hyperglycemia. BioMed Central 2008 2008-05-16 /pmc/articles/PMC2481442/ /pubmed/18495050 http://dx.doi.org/10.1186/cc6889 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Commentary
Krinsley, James S
Preiser, Jean-Charles
Moving beyond tight glucose control to safe effective glucose control
title Moving beyond tight glucose control to safe effective glucose control
title_full Moving beyond tight glucose control to safe effective glucose control
title_fullStr Moving beyond tight glucose control to safe effective glucose control
title_full_unstemmed Moving beyond tight glucose control to safe effective glucose control
title_short Moving beyond tight glucose control to safe effective glucose control
title_sort moving beyond tight glucose control to safe effective glucose control
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481442/
https://www.ncbi.nlm.nih.gov/pubmed/18495050
http://dx.doi.org/10.1186/cc6889
work_keys_str_mv AT krinsleyjamess movingbeyondtightglucosecontroltosafeeffectiveglucosecontrol
AT preiserjeancharles movingbeyondtightglucosecontroltosafeeffectiveglucosecontrol